Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
951 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Unknown  A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
5 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
6 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
7 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
8 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
9 Recruiting A Phase 1 Trial for Evaluation of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)
Condition: Prostate Cancer
Interventions: Drug: CTT1057;   Procedure: Prostatectomy
10 Not yet recruiting SPCG17: Prostate Cancer Active Surveillance Trigger Trial
Condition: Prostate Cancer
Intervention: Procedure: Active surveillance
11 Not yet recruiting Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Radiotherapy to the pelvis;   Drug: Hormonal therapy (LHRH agonist and/or antiandrogens)
12 Not yet recruiting Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Condition: Prostate Cancer Metastatic
Interventions: Drug: Apalutamide;   Drug: Abiraterone acetate;   Drug: Docetaxel;   Drug: Prednisone
13 Recruiting Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Endorectal Balloon;   Device: Rectal Spacer;   Radiation: Radiation therapy
14 Recruiting Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
Condition: Prostatic Cancer
Interventions: Drug: MIDAZOLAM;   Drug: MEPIVACAÍNE;   Drug: FENTANILE;   Drug: KETAMINE
15 Not yet recruiting Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer
Condition: Metastatic Castration-resistant Prostate Cancer (CRPCa)
Interventions: Other: neuropsychologic evaluation;   Other: oncogeriatric evaluation
16 Not yet recruiting A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: JNJ-809;   Drug: Apalutamide
17 Recruiting PACCT: Partnering Around Cancer Clinical Trials
Condition: Prostate Cancer
Interventions: Behavioral: Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams;   Behavioral: Physicians: Educational Module
18 Not yet recruiting Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Palbociclib
19 Not yet recruiting A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Intervention:
20 Not yet recruiting Neoadjuvant And Adjuvant Abiraterone Acetate + Aptilutamide Prostate Cancer Undergoing Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: Aptilutamide;   Drug: Leuprolide;   Drug: Prednisone;   Drug: Abiraterone Acetate;   Procedure: Radical Prostatectomy;   Other: Observation-Post RP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years